136 related articles for article (PubMed ID: 31753813)
1. Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in
Dietz S; Christopoulos P; Gu L; Volckmar AL; Endris V; Yuan Z; Ogrodnik SJ; Zemojtel T; Heussel CP; Schneider MA; Meister M; Muley T; Reck M; Schlesner M; Thomas M; Stenzinger A; Sültmann H
Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31753813
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer.
Park CK; Kim JE; Kim MS; Kho BG; Park HY; Kim TO; Shin HJ; Cho HJ; Choi YD; Oh IJ; Kim YC
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2071-2082. PubMed ID: 31154543
[TBL] [Abstract][Full Text] [Related]
3. ALK-rearrangement in non-small-cell lung cancer (NSCLC).
Du X; Shao Y; Qin HF; Tai YH; Gao HJ
Thorac Cancer; 2018 Apr; 9(4):423-430. PubMed ID: 29488330
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing.
Wang Y; Tian PW; Wang WY; Wang K; Zhang Z; Chen BJ; He YQ; Li L; Liu H; Chuai S; Li WM
Oncotarget; 2016 Oct; 7(40):65208-65217. PubMed ID: 27564104
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment with Crizotinib to Overcome Drug Resistance Possibly Due to Mesenchymal-epithelial Transition Amplification in a Lung Cancer Patient with the Echinoderm Microtubule-associated Protein-like 4-anaplastic Lymphoma Kinase Fusion Gene.
Shiraishi T; Yamasaki K; Kidogawa M; Shingu T; Ujimiya F; Jotatsu T; Matsumoto S; Izumi H; Nishida C; Goto K; Yatera K
Intern Med; 2023 Nov; 62(21):3215-3221. PubMed ID: 36927974
[TBL] [Abstract][Full Text] [Related]
6. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Zheng J; Wang T; Yang Y; Huang J; Feng J; Zhuang W; Chen J; Zhao J; Zhong W; Zhao Y; Zhang Y; Song Y; Hu Y; Yu Z; Gong Y; Chen Y; Ye F; Zhang S; Cao L; Fan Y; Wu G; Guo Y; Zhou C; Ma K; Fang J; Feng W; Liu Y; Zheng Z; Li G; Wang H; Cang S; Wu N; Song W; Liu X; Zhao S; Ding L; Selvaggi G; Wang Y; Xiao S; Wang Q; Shen Z; Zhou J; Zhou J; Zhang L
Cancer Commun (Lond); 2024 Apr; 44(4):455-468. PubMed ID: 38421881
[TBL] [Abstract][Full Text] [Related]
7. ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling.
Itchins M; Lau B; Hudson AL; Westman H; Xia CY; Hayes SA; Howell VM; Rodriguez M; Cooper WA; Wei H; Buckland M; Li BT; Li M; Rathi V; Fox SB; Gill AJ; Clarke SJ; Boyer MJ; Pavlakis N
Oncologist; 2020 Aug; 25(8):641-649. PubMed ID: 32558067
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic lymphoma kinase (ALK)-rearranged pulmonary pleomorphic carcinoma successfully treated with crizotinib.
Lin L; Huang F; Chen F; He Y; Hu J; Cao X
J Int Med Res; 2018 Aug; 46(8):3491-3497. PubMed ID: 29310482
[TBL] [Abstract][Full Text] [Related]
9. Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations.
Alidousty C; Baar T; Martelotto LG; Heydt C; Wagener S; Fassunke J; Duerbaum N; Scheel AH; Frank S; Holz B; Binot E; Kron A; Merkelbach-Bruse S; Ihle MA; Wolf J; Buettner R; Schultheis AM
J Pathol; 2018 Sep; 246(1):67-76. PubMed ID: 29885057
[TBL] [Abstract][Full Text] [Related]
10. Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting.
Testa U; Castelli G; Pelosi E
Tumori; 2024 Apr; 110(2):88-95. PubMed ID: 37772924
[TBL] [Abstract][Full Text] [Related]
11. Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice.
Hofman P
Cells; 2021 Jan; 10(1):. PubMed ID: 33467720
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy.
Wang S; Hao X; Dai L; Lou N; Fan G; Gao R; Yang M; Xing P; Liu Y; Wang L; Zhang Z; Yao J; Tang L; Shi Y; Han X
Lung Cancer; 2024 Mar; 189():107503. PubMed ID: 38359741
[TBL] [Abstract][Full Text] [Related]
13. Environment-Sensitive Fluorescent Probe Enables Assessment of Anaplastic Lymphoma Kinase Activity in Nonsmall Cell Lung Cancer.
Zhou X; Lei Q; Xiao Z; Song C; Deng H
Anal Chem; 2024 Feb; 96(8):3525-3534. PubMed ID: 38345335
[TBL] [Abstract][Full Text] [Related]
14. Improving the management of ALK-rearranged non-small-cell lung cancer through a mobile application: a physicians-based survey.
Elkaddoum R; Zakhour J; Hajal M; Aoun M; Njeim M; Mahrous M; Al-Shamsi HO; Brahim ZB; Khatib SA; Kourie HR
Pharmacogenomics; 2023 Aug; 24(13):725-730. PubMed ID: 37706248
[No Abstract] [Full Text] [Related]
15. Targeting ALK: Precision Medicine Takes on Drug Resistance.
Lin JJ; Riely GJ; Shaw AT
Cancer Discov; 2017 Feb; 7(2):137-155. PubMed ID: 28122866
[TBL] [Abstract][Full Text] [Related]
16. ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.
Mota I; Patrucco E; Mastini C; Mahadevan NR; Thai TC; Bergaggio E; Cheong TC; Leonardi G; Karaca-Atabay E; Campisi M; Poggio T; Menotti M; Ambrogio C; Longo DL; Klaeger S; Keshishian H; Sztupinszki ZM; Szallasi Z; Keskin DB; Duke-Cohan JS; Reinhold B; Carr SA; Wu CJ; Moynihan KD; Irvine DJ; Barbie DA; Reinherz EL; Voena C; Awad MM; Blasco RB; Chiarle R
Nat Cancer; 2023 Jul; 4(7):1016-1035. PubMed ID: 37430060
[TBL] [Abstract][Full Text] [Related]
17. Primary resistance to ALK inhibitors in
Siblini L; Schott R; Trensz P; Pencreach E; Bender L
Transl Lung Cancer Res; 2023 Nov; 12(11):2342-2346. PubMed ID: 38090529
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous ALK rearranged spindle cell neoplasm and S-100/CD34 co-expression: report of a case].
Zhang W; Wang Y; Wang H; Gao Y; Chen YL
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):498-500. PubMed ID: 38678336
[TBL] [Abstract][Full Text] [Related]
19. Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic
Huang Y; Zhang S; Hu X; Wang X; Zhao Y; Li Z
AME Case Rep; 2024; 8():38. PubMed ID: 38711893
[TBL] [Abstract][Full Text] [Related]
20. Detection of an
Lai AZ; Schrock AB; Erlich RL; Ross JS; Miller VA; Yakirevich E; Ali SM; Braiteh F
Oncologist; 2017 Jul; 22(7):774-779. PubMed ID: 28507204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
